Skip to main content

Hospital Harm-Acute Kidney Injury

CBE ID
3713e
Endorsed
New or Maintenance
New
Is Under Review
No
E&M Cycle Comments

Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Fall 2022 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Fall 2022 “Intent to Submit.” Battelle took over the E&M work for the Fall 2022 cycle after developers and/or stewards submitted their full measure information to NQF, which for CBE #3713e, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2024-02/3713e.zip

Battelle took over the E&M work beginning with the public comment period to close the E&M committees for the post-comment meeting, convening the CSAC to render a final endorsement decision, and executing the appeals period.

 

Measure Description
This electronic clinical quality measure (eCQM) assesses the proportion of inpatient hospitalizations for patients 18 years of age or older who have an acute kidney injury (stage 2 or greater) that occurred during the encounter. Acute kidney injury (AKI) stage 2 or greater is defined as a substantial increase in serum creatinine value, or by the initiation of kidney dialysis (continuous renal replacement therapy (CRRT), hemodialysis or peritoneal dialysis).
  • Measure Type
    Outcome
    MAT output not attached
    Attached
    Data dictionary not attached
    No
    Numerator

    Inpatient hospitalizations for patients who develop acute kidney injury (AKI) (stage 2 or greater) during the encounter, as evidenced by: • A subsequent increase in serum creatinine value at least 2 times higher than the lowest serum creatinine value, and the increased value is greaterthan the highest sex-specific normal value for serum creatinine; or • Kidney dialysis (continuous renal replacement therapy (CRRT), hemodialysis or peritoneal dialysis) initiated 48 hours or more after the start of theencounter.

    Denominator

    Inpatient hospitalizations for patients 18 years of age or older at the start if the encounter without a diagnosis of obstetrics, with a length of stay of 48 hours or longer who had at least one serum creatinine value after 48 hours from the start of the encounter.

    All information required to stratify the measure results
    Off
    All information required to stratify the measure results
    Off
  • Risk adjustment approach
    Off
    Risk adjustment approach
    Off
    Conceptual model for risk adjustment
    Off
    Conceptual model for risk adjustment
    Off
  • Most Recent Endorsement Activity
    Endorsed Patient Safety Fall 2022
    Initial Endorsement
    Next Planned Maintenance Review
    Fall 2027
    Endorsement Status
    Endorsed
    Last Updated
  • Do you have a secondary measure developer point of contact?
    Off
    Measure Developer Secondary Point Of Contact

    United States

    The measure developer is NOT the same as measure steward
    Off
    Steward
    Centers for Medicare & Medicaid Services
    Steward Organization Email
    [email protected]
    Steward Address

    United States

  • Detailed Measure Specifications
    No
    Logic Model
    Off
    Impact and Gap
    No
    Feasibility assessment methodology and results
    No
    Address health equity
    No
    Measure’s use or intended use
    No
    508 Compliance
    Off
    If no, attest that all information will be provided in other fields in the submission.
    Off